Vir Biotechnology (VIR) Treasury Shares (2018 - 2025)

Vir Biotechnology has disclosed Treasury Shares across 8 years of filings, most recently posting $5.7 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at $5.7 million, up 14.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.7 million (up 14.23% YoY), and the FY2025 annual result was $5.7 million, up 14.23% from the prior year.
• Treasury Shares came in at $5.7 million for Q4 2025 at Vir Biotechnology, up from $5.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.7 million in Q4 2025 to a low of $36298.0 in Q1 2021.
• The 5-year median for Treasury Shares is $2.7 million (2022), against an average of $2.9 million.
• Across the five-year window, Treasury Shares sank 97.51% in 2021 and surged 7452.44% in 2022, its largest moves.
• Vir Biotechnology's Treasury Shares stood at $1.3 million in 2021, then jumped by 109.84% to $2.7 million in 2022, then surged by 80.11% to $4.8 million in 2023, then rose by 3.67% to $5.0 million in 2024, then rose by 14.23% to $5.7 million in 2025.
• The last three Treasury Shares figures came in at $5.7 million (Q4 2025), $5.0 million (Q4 2024), and $4.8 million (Q4 2023), per Business Quant data.